52 min listen
First Rounder: Colin Goddard
FromFirst Rounders
ratings:
Length:
58 minutes
Released:
May 28, 2015
Format:
Podcast episode
Description
Colin Goddard is former CEO of OSI Pharmaceuticals, and current chairman and CEO of Coferon. His conversation with Nature Biotechnology details the history behind OSI's blockbuster drug Tarceva (erlotinib), the benefits of having a British accent in the United States and how to survive a hostile takeover. Hosted on Acast. See acast.com/privacy for more information.
Released:
May 28, 2015
Format:
Podcast episode
Titles in the series (61)
First Rounder: Una Ryan: Nature Biotechnology podcast by First Rounders